Pentagon Mandates Testosterone Screening for Troops Over 30, but Treatment Remains Voluntary

Pentagon Mandates Testosterone Screening for Troops Over 30, but Treatment Remains Voluntary

A finalized July 15, 2026 Defense Department memorandum (OSD004430-26) requires annual testosterone deficiency screening for all U.S. service members over 30, voluntary for those under 30. Screenings include women. Deficient members may opt into testosterone replacement therapy but cannot be compelled to accept it — a distinction that raises practical questions about how voluntary opt-in functions within the military chain of command.

Published

Read at another depth